RxDoctor Payments Data

Daniel Hsia

Pediatric Endocrinology · Atlanta, GANPI 1417140997

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,950 of the $6,394 with a category attached, or 77.4%. Eli Lilly accounts for 99.7% of it on its own, with 1 other manufacturer making up the rest.

$6,394in general payments, 2019–2025

Across 10 payments — averaging $639.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$6K
  • Insulet Corporation$21
$1,814,449in research payments, 2019–2025

Across 1,681 payments — averaging $1079.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$798K
  • Eli Lilly$429K
  • Novo Nordisk AS$332K
  • Vivus LLC$126K
  • Takeda Pharmaceuticals U.S.A., Inc.$79K
  • Janssen Research & Development, LLC$32K
  • plus $19K from 1 others

What the payments were for

  • Consulting fees$4,95077%
  • Travel & lodging$1,05617%
  • Food & beverage$3886%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly9$6,373
Insulet Corporation1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,394 in reported general payments places this provider in the 75th percentile of 30 pediatric endocrinology providers in Georgia.

See all pediatric endocrinology providers in Georgia

Other pediatric endocrinology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →